BBI Solutions to Showcase Technologies for Next-Generation Diagnostics
By LabMedica International staff writers Posted on 15 Nov 2017 |
Image: BBI Solutions will showcase its Morffi signal enhancement technology at MEDICA 2017, the world’s largest medical trade fair (Photo courtesy of BBI Solutions).
Immunoassay development and manufacturing specialist BBI Solutions (Cardiff, UK) will showcase its award-winning Morffi signal enhancement technology at the world’s largest medical trade fair, MEDICA 2017, which runs from November 13 to 16 in Dusseldorf, Germany. The Morffi signal enhancement technology is a patent pending conjugate blocking technology that could provide a two-fold enhancement in the limit of detection in both plasma and urine as compared to existing gold conjugation methods; enabling lateral flow immunoassays to compete with traditional lab-based testing platforms.
Additionally, BBI Solutions, along with its sister company, BBI Group’s mobile arm, Novarum (Scotland, UK), will showcase their innovative mobile technology which allows users to read and share results of lateral flow diagnostic tests using just a smartphone. The company’s smartphone readers enable tests to be accurately read from the point of care, at a patient’s home or in remote and challenging environments, with the results shared securely with healthcare professionals or specific end-users.
“This is an incredibly exciting period of growth and innovation for the business. We’re looking forward to the opportunity to outline BBI Solutions’ enhanced capabilities and showcase the potential presented by our landmark Morffi technology,” said Liam Taylor, managing director of BBI Solutions. “The combined impact of BBI Solutions’ and Novarum’s technology offers an outstanding end-to-end solution that has the potential to revolutionize the lateral flow diagnostics landscape and we relish the chance to showcase this compelling proposition during the event.”
Additionally, BBI Solutions, along with its sister company, BBI Group’s mobile arm, Novarum (Scotland, UK), will showcase their innovative mobile technology which allows users to read and share results of lateral flow diagnostic tests using just a smartphone. The company’s smartphone readers enable tests to be accurately read from the point of care, at a patient’s home or in remote and challenging environments, with the results shared securely with healthcare professionals or specific end-users.
“This is an incredibly exciting period of growth and innovation for the business. We’re looking forward to the opportunity to outline BBI Solutions’ enhanced capabilities and showcase the potential presented by our landmark Morffi technology,” said Liam Taylor, managing director of BBI Solutions. “The combined impact of BBI Solutions’ and Novarum’s technology offers an outstanding end-to-end solution that has the potential to revolutionize the lateral flow diagnostics landscape and we relish the chance to showcase this compelling proposition during the event.”
Latest Industry News
- Beckman Coulter and MeMed Expand Host Immune Response Diagnostics Partnership
- Thermo Fisher and Bio-Techne Enter Into Strategic Distribution Agreement for Europe
- ECCMID Congress Name Changes to ESCMID Global
- Bosch and Randox Partner to Make Strategic Investment in Vivalytic Analysis Platform
- Siemens to Close Fast Track Diagnostics Business
- Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics
- Sysmex and Hitachi Collaborate on Development of New Genetic Testing Systems
- Sysmex and CellaVision Expand Collaboration to Advance Hematology Solutions
- BD and Techcyte Collaborate on AI-Based Digital Cervical Cytology System for Pap Testing
- Medlab Middle East 2024 to Address Transformative Potential of Artificial Intelligence
- Seegene and Microsoft Collaborate to Realize a World Free from All Diseases and Future Pandemics
- Medlab Middle East 2024 to Highlight Importance of Sustainability in Laboratories
- Fujirebio and Agappe Collaborate on CLIA-Based Immunoassay
- Medlab Middle East 2024 to Highlight Groundbreaking NextGen Medicine
- bioMérieux Acquires Software Company LUMED to Support Fight against Antimicrobial Resistance
- Roche Acquires LumiraDx's Point of Care Technology for USD 295 Million